Clinical Trial Update: Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating dapagliflozin for improving kidney function and cardiovascular health in kidney transplant recipients; the study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Diabetes Mellitus
• End-stage Kidney Disease

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Kidney Transplant; Complications, Vascular Diseases | Phase 4 | Status: RECRUITING